The upgrade of the bonds by multiple notches from “B-” to “A+” reflects Wellstar’s credit profile, which appears to be able to absorb the Augusta system, now known as Wellstar MCG Health, even as the transaction is initially dilutive, S&P said.
Wellstar, which has come under criticism for the abrupt closure of two Atlanta medical centers in less affluent areas close to the takeover of Wellstar MCG Health, has pledged $800 million in investment over a 10-year period in Wellstar MCG.
A CreditWatch with negative implications placed on the affected 2018 revenue bonds was also removed, according to the note. The outlook is stable.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
